Business

NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier

Financial Post · September 1, 2026 at 7:05 a.m.

Pharmaceutical industry leader brings more than 20 years of global drug development, regulatory strategy and portfolio leadership experience across AbbVie, Merck KGaA, AstraZeneca and Abivax TORONTO, Sept.

01, 2026 (GLOB

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier

More from Financial Post

INDROTEK Announces InDro Robotics Selected as Qualified Supplier Under Canada’s Defence Drone Initiative Marketplace

Philip Morris International to Host Webcast of Fireside Chat Session at Barclays Global Consumer Conference

China makes cars so quickly that regulators are getting worried

The Search is On: Decode Air Canada’s Next Routes to Win

More in Business

INDROTEK Announces InDro Robotics Selected as Qualified Supplier Under Canada’s Defence Drone Initiative Marketplace

Philip Morris International to Host Webcast of Fireside Chat Session at Barclays Global Consumer Conference

China makes cars so quickly that regulators are getting worried

The Search is On: Decode Air Canada’s Next Routes to Win

VivoSim Labs to Add Rat Liver Model to NAMkind Platform

Aduro Clean Technologies Reports Fourth Quarter and Fiscal Year 2026 Results and Provides Business Update